Entrada Therapeutics, Inc.(TRDA:US)

Market Cap$170.15M

Key Metrics

Price$4.37

Revenue (TTM)$4.69M

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$165.78M

EBITDA (TTM)-$172.76M

Op. Margin (TTM)-3.77K%

Dividend Yield-

Holders Yield-

Cash on hand$99.28M

Total Assets$298.88M

Net Assets$233.41M

Total Debt$48.54M

Entrada Therapeutics, Inc.(TRDA:US)

Market Cap$170.15M

Price history

Key Metrics

Price$4.37

Revenue (TTM)$4.69M

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$165.78M

EBITDA (TTM)-$172.76M

Op. Margin (TTM)-3.77K%

Dividend Yield-

Holders Yield-

Cash on hand$99.28M

Total Assets$298.88M

Net Assets$233.41M

Total Debt$48.54M

Financials

NameJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Revenue
$898K$875K$1.3M$1.61M$1.95M$20.56M$37.4M$19.57M$94.69M$59.12M$41.85M$43.74M$18.17M$25.26M$0$0$0$0$0$0$0$0$0$0
Cost of Revenue
------------------------
Gross Profit
------------------------
$45.86M$43.18M$43.51M$48.67M$48.8M$42.35M$43.27M$41.23M$41.27M$38.01M$36.94M$29.72M$34.47M$31.04M$25.58M$25.94M$23.58M$22.15M$18.46M$14.36M$9.91M$8.39M$8.65M$6.97M
Research and Development$35.37M$33.05M$33.96M$38.36M$37.88M$32.07M$33.41M$31.26M$32.04M$28.61M$28.29M$22.19M$26.3M$23.1M$15.69M$18.96M$16.25M$15.72M$12.36M$10.51M$6.83M$6.22M$6.66M$5.7M
Selling, General, and Administrative$10.49M$10.12M$9.55M$10.3M$10.92M$10.27M$9.86M$9.97M$9.24M$9.4M$8.65M$7.53M$8.17M$7.94M$9.89M$6.98M$7.33M$6.43M$6.1M$3.85M$3.08M$2.17M$2M$1.27M
Other Operating Expenses------------------------
Operating Income
-$44.96M-$42.3M-$42.21M-$47.05M-$46.85M-$21.79M-$5.87M-$21.66M$53.42M$21.11M$4.91M$14.01M-$16.3M-$5.78M-$25.58M-$25.94M-$23.58M-$22.15M-$18.46M-$14.36M-$9.91M-$8.39M-$8.65M-$6.97M
$2.24M$2.62M$3.14M$3.57M$3.92M$4.44M$5.13M$5.77M$4.37M$4.21M$4.29M$4.05M$4.22M$2.66M-$799K$403K$480K--$9K$13K--
Non-Operating Interest Income$2.24M$2.62M$3.14M$3.57M$3.92M$4.44M$5.13M$5.77M$4.37M$4.21M$4.29M$4.05M$4.22M$2.66M-$799K$403K$480K--$9K$13K--
Non-Operating Interest Expense------------------------
Other Income/Expense------------------------
Income Before Tax
-$42.73M-$39.68M-$39.07M-$43.48M-$42.93M-$17.35M-$739K-$15.89M$57.79M$25.33M$9.2M$18.06M-$12.08M-$3.12M-$24.63M-$25.14M-$23.18M-$21.67M-$18.45M-$14.43M-$9.9M-$8.38M-$8.67M-$6.99M
Income Tax
$35K$38K$92K$654K$178K$0-$1.87M-$1.86M$2.76M$1.83M$18.74M-$17.4M$13.85M$3.55M-$0$0$0------
Net Income
-$42.76M-$39.72M-$39.16M-$44.13M-$43.1M-$17.35M$1.13M-$14.03M$55.03M$23.5M-$9.54M$35.46M-$25.93M-$6.67M-$24.63M-$25.14M-$23.18M-$21.67M-$18.45M-$14.43M-$9.9M-$8.38M-$8.67M-$6.99M
Minority Interests
------------------------
Preferred Stock Dividends
------------------------
Net Income to Common
-$42.76M-$39.72M-$39.16M-$44.13M-$43.1M-$17.35M$1.13M-$14.03M$55.03M$23.5M-$9.54M$35.46M-$25.93M-$6.67M-$24.63M-$25.14M-$23.18M-$21.67M-$18.45M-$14.43M-$9.9M-$8.38M-$8.67M-$6.99M
Shares Outstanding (Basic)
42.22M41.84M41.6M41.46M41.34M41.07M40.84M40.63M34.18M33.5M-33.28M33.16M32.37M31.35M31.3M31.28M31.25M20.78M28.31M20.48M20.48M-20.48M
Shares Outstanding (Diluted)
42.22M41.84M41.6M41.46M41.34M41.07M43.05M40.63M35.51M34.79M-34.78M33.16M32.37M31.35M31.3M31.28M31.25M20.78M28.31M20.48M20.48M-20.48M
EPS (Basic)
-$1.01-$0.95-$0.94-$1.06-$1.04-$0.42$0.03-$0.35$1.61$0.70-$1.07-$0.78-$0.21-$0.79-$0.80-$0.74-$0.69-$0.89-$0.51-$0.48-$0.41--$0.34
EPS (Diluted)
-$1.01-$0.95-$0.94-$1.06-$1.04-$0.42$0.03-$0.35$1.55$0.68-$1.02-$0.78-$0.21-$0.79-$0.80-$0.74-$0.69-$0.89-$0.51-$0.48-$0.41--$0.34
EBIT
-$44.96M-$42.3M-$42.21M-$47.05M-$46.85M-$21.79M-$5.87M-$21.66M$53.42M$21.11M$4.91M$14.01M-$16.3M-$5.78M-$25.58M-$25.94M-$23.58M-$22.15M-$18.46M-$14.36M-$9.91M-$8.39M-$8.65M-$6.97M
EBITDA
-$44.12M-$41.5M-$41.32M-$45.82M-$45.82M-$20.84M-$4.88M-$20.72M$54.33M$22.05M$5.64M$14.85M-$15.57M-$5.24M-$25.05M-$25.42M-$23.12M-$21.76M-$18.1M-$14.06M-$9.66M-$8.19M-$8.56M-$6.88M